TRITON-CM: A Phase 3 Global, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Nucresiran in Patients with Transthyretin-Mediated Amyloidosis with Cardiomyopathy (ATTR amyloidosis with cardiomyopathy)

16395TRITON-CMOpenTRITON-CM: A Phase 3 Global, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Nucresiran in Patients with Transthyretin-Mediated Amyloidosis with Cardiomyopathy (ATTR amyloidosis with cardiomyopathy)ALN-TTRSC04-003IndustrialAdultTreatmentOtherSheikh, FarooqMedstar Washington Hospital Center : Jamie Guillergan, Maninder KaurMCRN - Heart Failure16692Jamie GuillerganJamie Guillerganjamie.s.guillergan@medstar.net17648Maninder KaurManinder KaurManinder.Kaur@medstar.net2026.1.0 Build 16 <a href="https://advarra.com" target="_blank">© 2026 Advarra, Inc.</a>